当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:56.41亿  总市值:56.41亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,290,403,815.21,502,638,809.68747,214,773.763,113,315,039.95
  收到的税费返还322,196322,196--
  收到其他与经营活动有关的现金240,428,310.16208,681,101.4479,887,323.52254,782,413.3
  经营活动现金流入小计2,531,154,321.361,711,642,107.12827,102,097.283,368,097,453.25
  购买商品、接受劳务支付的现金404,508,949.55206,734,077.48128,028,012.25803,042,751.9
  支付给职工以及为职工支付的现金296,880,569.56203,476,143.11102,980,785.59414,983,189.84
  支付的各项税费237,276,526.76175,333,647.481,373,693.95334,185,410.32
  支付其他与经营活动有关的现金1,026,674,889.11698,964,914.2322,182,627.751,349,511,518.69
  经营活动现金流出小计1,965,340,934.981,284,508,782.19634,565,119.542,901,722,870.75
  经营活动产生的现金流量净额565,813,386.38427,133,324.93192,536,977.74466,374,582.5
二、投资活动产生的现金流量:
  取得投资收益收到的现金115,861,984.8990,784,019.2428,109,094.9153,115,957.56
  处置固定资产、无形资产和其他长期资产收回的现金净额183,160121,20087,7003,355,581.58
  收到的其他与投资活动有关的现金5,737,554,016.143,149,534,016.141,227,534,016.141,359,435,780.1
  投资活动现金流入小计5,853,599,161.033,240,439,235.381,255,730,811.041,515,907,319.24
  购建固定资产、无形资产和其他长期资产支付的现金25,890,695.6520,823,460.2512,706,277.8764,762,582.27
  投资支付的现金100,000---
  支付其他与投资活动有关的现金6,210,200,0003,363,200,0001,790,200,0001,624,965,281.75
  投资活动现金流出小计6,236,190,695.653,384,023,460.251,802,906,277.871,689,727,864.02
  投资活动产生的现金流量净额-382,591,534.62-143,584,224.87-547,175,466.83-173,820,544.78
三、筹资活动产生的现金流量:
  取得借款收到的现金---15,344,800
  收到其他与筹资活动有关的现金-44,996,554.68--12,083,833.11
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计-44,996,554.68--27,428,633.11
  偿还债务支付的现金6,321,307.957,473,148.792,107,102.6570,807,780.18
  分配股利、利润或偿付利息支付的现金174,574,282.5974,694,472.9275,847.66185,162,801.43
  其中:子公司支付给少数股东的股利、利润---2,240,000
  支付其他与筹资活动有关的现金44,996,554.681,412,382.26-3,418,179.86
  筹资活动现金流出小计225,892,145.2283,580,003.972,182,950.31259,388,761.47
  筹资活动产生的现金流量净额-270,888,699.9-83,580,003.97-2,182,950.31-231,960,128.36
四、汇率变动对现金及现金等价物的影响-4,616,391.15-3,337,736.34-1,416,275.05-793,399.29
五、现金及现金等价物净增加额-92,283,239.29196,631,359.75-358,237,714.4559,800,510.07
  加:期初现金及现金等价物余额1,212,075,732.871,212,075,732.871,212,075,732.871,120,473,303.89
  期末现金及现金等价物余额1,119,792,493.581,408,707,092.62853,838,018.421,180,273,813.96
补充资料:
  净利润-266,953,312.48-425,618,864.59
  资产减值准备-36,521,281.08-10,186,190.21
  固定资产和投资性房地产折旧-101,770,691.17-190,068,914.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-101,770,691.17-190,068,914.4
  无形资产摊销-3,881,243.38-9,025,039.11
  长期待摊费用摊销-393,951.72-471,157.21
  处置固定资产、无形资产和其他长期资产的损失--10,761.04-707,422.32
  固定资产报废损失-35,923.51-664,130.83
  公允价值变动损失--30,871,564.66--39,679,633.48
  财务费用--9,403,290-2,128,986.49
  投资损失--91,138,677.54--123,468,458.42
  递延所得税--248,598.98-6,337,254.55
  其中:递延所得税资产减少--1,143,368.32--923,081.54
    递延所得税负债增加-894,769.34-7,260,336.09
  存货的减少-32,696,796.45-178,690,374.61
  经营性应收项目的减少--166,503,993.15--102,236,759.86
  经营性应付项目的增加--61,844,993.75--143,995,589.11
  其他-333,340,779.96--9,342,430.2
  现金的期末余额-1,408,707,092.62-1,180,273,813.96
  减:现金的期初余额-1,212,075,732.87-1,120,473,303.89
  现金及现金等价物的净增加额-196,631,359.75-59,800,510.07
公告日期2026-10-282026-08-252026-04-292026-04-03
审计意见(境内)标准无保留意见
TOP↑